Cefdinir Capsule
Product Images NDC 68180-711

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68180-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir Usp (Cefdinir Figure 01)

Cefdinir Usp (Cefdinir Figure 01)
Chemical structure diagram of Cefdinir, illustrating its molecular framework with rings and functional groups typical for this active ingredient.*
FDA Label Image

Cefdinir Capsules Usp (Cefdinir Figure 02)

Cefdinir Capsules Usp (Cefdinir Figure 02)
Label for Cefdinir Capsules USP 300 mg by Lupin Pharmaceuticals, Inc. The label indicates each capsule contains 300 mg of cefdinir USP, with a package size of 60 capsules. Storage instructions include keeping at 20°-25°C (68°-77°F). The label includes NDC 68180-711-60 and references Lupin Limited as the manufacturer in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.